Tuesday, June 4, 2019

What Emergent’s latest $535M contract means for national ‘smallpox franchise’

The product is the only therapy approved by the Food and Drug Administration for smallpox vaccine complications.



from https://www.bizjournals.com/baltimore/news/2019/06/04/what-emergent-s-latest-535m-contract-means-for.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/185360019447

No comments:

Post a Comment